AGN Price sensitive 15 Oct 2025, 8:28 AM

Phase 2 Trial Promising Improvements in Functional Outcomes

Argenica Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in